Search results
Author(s):
John Rawlins
,
Jehangir Din
,
Suneel Talwar
,
et al
Added:
3 years ago
A bifurcation lesion within the coronary arterial circulation is defined as a stenosis occurring at, or adjacent to, a significant division of a major epicardial coronary artery.1 Bifurcation lesions account for 1–20% of all percutaneous coronary interventions (PCIs), and treatment remain technically challenging despite advances in PCI techniques and third-generation drug-eluting stent (DES)…
View more
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Author(s):
Maciej Lesiak
Added:
3 years ago
While provisional stenting has remained the preferred strategy for majority of bifurcation lesions, controversies still exist regarding when and how to use complex techniques. Most of randomised studies comparing simple and complex approaches have focused on selected populations, included both ‘true’ and ‘non-true’ bifurcation lesions, used first-generation drug eluting stents (DES) and favoured…
View more
Author(s):
Angela Hoye
,
Scot Garg
Added:
3 years ago
Coronary artery bifurcations are at an increased risk of the development of coronary atherosclerosis because of turbulent flow and low shear stress. Bifurcation lesions account for between 8% and 22% of all percutaneous coronary interventions (PCI) and have long posed a problem for interventional cardiologists.
Published data show bifurcation lesions treated using bare metal stents (BMS) have…
View more
Author(s):
Shao-Liang Chen
,
Imad Sheiban
Added:
3 years ago
Bifurcation lesions account for approximately 20–30% of all percutaneous coronary interventions (PCIs). Coronary bifurcation sites are prone to developing obstructive atherosclerotic disease due to turbulent blood flow and change of shear stress. With the complexity of bifurcation lesions, several classification systems have been advocated in order to extablish percutaneous strategies.1–3 In fact…
View more
John Rawlins
Research Area(s) / Expertise:
Job title: Consultant Interventional Cardiologist
Author
Dedicated Bifurcation Drug-eluting Stent BiOSS® – A Novel Device for Coronary Bifurcation Treatment
Author(s):
Robert Gil
,
Dobrin Vassilev
,
Jacek Bil
Added:
3 years ago
Article
Author(s):
Joanna J Wykrzykowska
,
Willem J van der Giessen
Added:
3 years ago
Approach to the Bifurcation Patient
Historically, bifurcation lesions have been associated with lower procedural success and a poorer clinical outcome than non-bifurcation lesions. This may be due to the technical difficulty of the procedure but also due to the complexity of the patients. According to the recently presented LEADERS trial sub-study,1 patients who have bifurcation disease are…
View more
Author(s):
Jacek Bil
,
Robert Gil
,
Dobrin Vassilev
Added:
8 years ago
Author(s):
Philippe Brenot
,
Thierry Royer
,
Gerard Marti
,
et al
Added:
3 years ago
A true bifurcated lesion in coronary atherosclerotic disease is present in approximately 15% of patients referred for percutaneous coronary intervention (PCI).1 The percutaneous approach to this especially complex scenario has been faced in many different ways depending on the techniques available at any particular time.2–4 In the last few years, the introduction of drug-eluting stents (DES) has…
View more